Rational evaluation of urinary stone disease
- PMID: 16450128
- DOI: 10.1007/s00240-005-0024-2
Rational evaluation of urinary stone disease
Abstract
This article outlines the recent state of the art in the metabolic diagnosis of stone disease. The current literature in the field of urolithiasis-including the existing German and EAU-Guidelines as well as the Conference Book of the 1st International Consultation on Stone Disease-was critically reviewed. As far as possible the references were rated according to the EBM criteria. The occurrence of stone disease in the western world is increasing greatly. Modern lifestyle, dietary habits and excess weight-problems of affluent societies-are emerging as the important promoters of the "stone boom" in the new millennium. This even affects children, whose stone prevalence is otherwise significantly less than that of adults. Criteria for the high-risk group of stone formers were clearly defined. A diagnostic standard is formulated for the basic and the elaborate metabolic evaluation of a stone patient. The diagnostic pathways for the most important stone types and metabolic disorders, respectively, are described. The present concept allows a precise risk classification of each stone former and facilitates the decision whether stone-specific measures in addition to the basic metaphylaxis are recommendable or not.
Similar articles
-
Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.World J Urol. 2005 Nov;23(5):309-23. doi: 10.1007/s00345-005-0029-z. Epub 2005 Nov 29. World J Urol. 2005. PMID: 16315051 Review.
-
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20. Eur Urol. 2015. PMID: 25454613
-
Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.Clin Chem Lab Med. 2004 Mar;42(3):283-93. doi: 10.1515/CCLM.2004.052. Clin Chem Lab Med. 2004. PMID: 15080561
-
Association between body mass index, lipid profiles, and types of urinary stones.Ren Fail. 2012;34(9):1140-3. doi: 10.3109/0886022X.2012.713298. Epub 2012 Aug 14. Ren Fail. 2012. PMID: 22889148
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
Cited by
-
Medication-based urolithiasis and atazanavir.CMAJ. 2011 Aug 9;183(11):E748-51. doi: 10.1503/cmaj.100019. Epub 2011 Mar 28. CMAJ. 2011. PMID: 21444613 Free PMC article. No abstract available.
-
[What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].Urologe A. 2006 Nov;45(11):1387-8, 1390-1. doi: 10.1007/s00120-006-1224-2. Urologe A. 2006. PMID: 17082926 German.
-
HIV medication-based urolithiasis.Clin Kidney J. 2014 Apr;7(2):121-6. doi: 10.1093/ckj/sfu008. Epub 2014 Mar 11. Clin Kidney J. 2014. PMID: 25852859 Free PMC article. Review.
-
Comparison of the bone mineral density status of patients with kidney stones stratified by stone composition.World J Urol. 2024 Jan 20;42(1):42. doi: 10.1007/s00345-023-04727-y. World J Urol. 2024. PMID: 38244092
-
Evaluation of children with urolithiasis.Indian J Urol. 2007 Oct;23(4):420-7. doi: 10.4103/0970-1591.36717. Indian J Urol. 2007. PMID: 19718299 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials